The Mathilda and Terence Kennedy Institute of Rheumatology Trust

Patent Applications and Registrations

Patent applications and USPTO patent grants for The Mathilda and Terence Kennedy Institute of Rheumatology Trust.The latest application filed is for "tnf-alpha antagonists and methotrexate in the treatment of tnf-mediated disease".

Company Profile

0.7.3

The Mathilda and Terence Kennedy Institute of Rheumatology Trust -
The Mathilda and Terence Kennedy Institute of Rheumatology Trust - London GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE App 20130064816 - Feldmann; Marc ; et al.	2013-03-14
Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate Grant 8,383,120 - Feldmann , et al. February 26, 2	2013-02-26
Concomitant treatment of rheumatoid arthritis with anti-TNF-.alpha. antibodies and methotrexate Grant 8,298,537 - Feldmann , et al. October 30, 2	2012-10-30
TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease App 20120141475 - Feldmann; Marc ; et al.	2012-06-07
TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease App 20120141474 - Feldmann; Marc ; et al.	2012-06-07
Activation and inhibition of the immune system Grant 7,915,009 - Foxwell , et al. March 29, 2	2011-03-29
Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate Grant 7,846,442 - Feldmann , et al. December 7, 2	2010-12-07
Methods of treating rheumatoid arthritis with p75 TNF-alpha receptor and methotrexate Grant 7,838,489 - Feldmann , et al. November 23, 2	2010-11-23
Methods for enhancing antigen presentation Grant 7,651,857 - Foxwell , et al. January 26, 2	2010-01-26
Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes Grant 7,390,630 - Brennan , et al. June 24, 2	2008-06-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.